Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Raposinho

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Neuroendocrinology|January 22, 2003
The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male ratP D Raposinho, R B White, M L Aubert
Endocrinology|December 7, 2000
Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axesP D Raposinho, E Castillo, V d'Alleves, et al.
Molecular and Cellular Endocrinology|December 12, 2001
Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadismP D Raposinho, D D Pierroz, P Broqua, et al.
Neuroendocrinology|January 25, 2000
Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male ratP D Raposinho, P Broqua, A Hayward, et al.
Endocrinology|August 28, 1999
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtypeP D Raposinho, P Broqua, D D Pierroz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Neuroendocrinology|January 22, 2003
The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male ratP D Raposinho, R B White, M L Aubert
Endocrinology|December 7, 2000
Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axesP D Raposinho, E Castillo, V d'Alleves, et al.
Molecular and Cellular Endocrinology|December 12, 2001
Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadismP D Raposinho, D D Pierroz, P Broqua, et al.
Neuroendocrinology|January 25, 2000
Stimulation of the gonadotropic axis by the neuropeptide Y receptor Y1 antagonist/Y4 agonist 1229U91 in the male ratP D Raposinho, P Broqua, A Hayward, et al.
Endocrinology|August 28, 1999
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtypeP D Raposinho, P Broqua, D D Pierroz, et al.
Pageof 1